Skip to Main Content

Author Details

Mark N Wass
University of Kent
2007
70
26
PMIDPaper TitleJournal TitlePublished Year
36938992Omicron-induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection.J Med Virol2023
36512325Impact of the COVID-19 pandemic on the circulation of other pathogens in England.J Med Virol2023
36644320Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform.iScience2023
36577096Drug Sensitivity of Currently Circulating Mpox Viruses.N Engl J Med2023
36681368Large inherent variability in data derived from highly standardised cell culture experiments.Pharmacol Res2023
36897017Repurposing of the antibiotic nitroxoline for the treatment of mpox.J Med Virol2023
35064226Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates.Cell Res2022
354126353DLigandSite: structure-based prediction of protein-ligand binding sites.Nucleic Acids Res2022
35538050SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment.Cell Discov2022
35917841Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants.J Infect2022
34111116Identification of sequence changes in myosin II that adjust muscle contraction velocity.PLoS Biol2021
33560365Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviour.Bioinformatics2021
33804833Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line.Cells2021
34641952Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells.J Exp Clin Cancer Res2021
34698067A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis.Curr Issues Mol Biol2021
32131402Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines.Cancers (Basel)2020
32102425Non-Phosphorylatable PEA-15 Sensitises SKOV-3 Ovarian Cancer Cells to Cisplatin.Cells2020
31828886Thiourea and Guanidine Compounds and Their Iridium Complexes in Drug-Resistant Cancer Cell Lines: Structure-Activity Relationships and Direct Luminescent Imaging.ChemMedChem2020
33199764Towards image-based cancer cell lines authentication using deep neural networks.Sci Rep2020
33143316Aprotinin Inhibits SARS-CoV-2 Replication.Cells2020
32751741COVID-19-Related Coagulopathy-Is Transferrin a Missing Link?Diagnostics (Basel)2020
32581304SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine.Commun Biol2020
32357518YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance Setting.Cancers (Basel)2020
32296088Miyabeacin: A new cyclodimer presents a potential role for willow in cancer therapy.Sci Rep2020
30972109A QTL for Number of Teats Shows Breed Specific Effects on Number of Vertebrae in Pigs: Bridging the Gap Between Molecular and Quantitative Genetics.Front Genet2019
35582596Drug-adapted cancer cell lines as preclinical models of acquired resistance.Cancer Drug Resist2019
31728254Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity.Beilstein J Nanotechnol2019
31744546The CAFA challenge reports improved protein function prediction and new functional annotations for hundreds of genes through experimental screens.Genome Biol2019
31849920Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2.Front Microbiol2019
31501742Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells.Beilstein J Nanotechnol2019
31581737Intact-Cell MALDI-ToF Mass Spectrometry for the Authentication of Drug-Adapted Cancer Cell Lines.Cells2019
31308405Environmental conditions shape the nature of a minimal bacterial genome.Nat Commun2019
30715291Understanding of researcher behavior is required to improve data reliability.Gigascience2019
31093647Is the Bombali virus pathogenic in humans?Bioinformatics2019
29867992Herd Immunity to Ebolaviruses Is Not a Realistic Target for Current Vaccination Strategies.Front Immunol2018
27486032Desulfovibrio vulgaris CbiK<sup>P</sup> cobaltochelatase: evolution of a haem binding protein orchestrated by the incorporation of two histidine residues.Environ Microbiol2017
28200119Changes associated with Ebola virus adaptation to novel species.Bioinformatics2017
28192521Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS.PLoS One2017
28812539Investigating Ebola virus pathogenicity using molecular dynamics.BMC Genomics2017
28812535Associating mutations causing cystinuria with disease severity with the aim of providing precision medicine.BMC Genomics2017
27009368Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses.Sci Rep2016
26589650The Role of Protein Modelling in Predicting the Disease Severity of Cystinuria.Eur Urol2016
27735941Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance.Cell Death Dis2016
27604469An expanded evaluation of protein function prediction methods shows an improvement in accuracy.Genome Biol2016
28066813Risks Posed by Reston, the Forgotten Ebolavirus.mSphere2016
27528741Computational analysis of Ebolavirus data: prospects, promises and challenges.Biochem Soc Trans2016
26887049Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transport.Oncotarget2016
25109415The genetic diversity of cystinuria in a UK population of patients.BJU Int2015
25906249Ten simple rules for a community computational challenge.PLoS Comput Biol2015
25950237The Phyre2 web portal for protein modeling, prediction and analysis.Nat Protoc2015
  • 1 - 50 of 70

Recommended Authors

Neeladri Sen
Institute of Structural and Molecular Biology, University College London
Career Start Year 2017
Number of shared co-authors 6
Matthew J O'Meara
University of Michigan ann arbor
Career Start Year 2013
Number of shared co-authors 2
Nan Zhao
Department of Computer Science and Informatics Institute, University of Missouri
Career Start Year 2007
Number of shared co-authors 1
Dmitry Korkin
Worcester Polytechnic Institute
Career Start Year 2002
Number of shared co-authors 1
Narcis Fernandez-Fuentes
Institute of Biological, Aberystwyth University
Career Start Year 2002
Number of shared co-authors 7
Dinesh Gupta
International Centre for Genetic Engineering and Biotechnology (ICGEB)
Career Start Year 2000
Number of shared co-authors 0
Jo??o P G L M Rodrigues
Stanford University
Career Start Year 1999
Number of shared co-authors 5
Daron M Standley
Osaka university
Career Start Year 1998
Number of shared co-authors 6
Patrick Aloy
Institucio Catalana de Recerca i Estudis Avancats (ICREA)
Career Start Year 1997
Number of shared co-authors 4
Erik Verschueren
University of California San Francisco
Career Start Year 1997
Number of shared co-authors 0
Roberto Sanchez
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 1
Krzysztof Paw??owski
Kashubian Center for Heart and Vascular Diseases in Wejherowo, Pomeranian Hospitals
Career Start Year 1996
Number of shared co-authors 3
Alex Bateman
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 1995
Number of shared co-authors 25
S??ndor Szalma
Takeda California Inc.
Career Start Year 1995
Number of shared co-authors 4
Ioannis Xenarios
University of Lausanne
Career Start Year 1994
Number of shared co-authors 30
Bonnie Berger
Massachusetts Institute of Technology
Career Start Year 1994
Number of shared co-authors 5
Baldo Oliva
Universitat Pompeu Fabra
Career Start Year 1991
Number of shared co-authors 2
Robert B Russell
Heidelberg University
Career Start Year 1991
Number of shared co-authors 1
Ram Samudrala
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Career Start Year 1990
Number of shared co-authors 1
Paul A Bates
The Francis Crick Institute
Career Start Year 1989
Number of shared co-authors 6
Roland L Dunbrack
Fox Chase Cancer Center
Career Start Year 1989
Number of shared co-authors 23
S??ren Brunak
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Career Start Year 1988
Number of shared co-authors 26
Adam Godzik
University of California Riverside
Career Start Year 1987
Number of shared co-authors 17
Mauno Vihinen
Lund University
Career Start Year 1987
Number of shared co-authors 23
Andrej Sali (CM4AI)
University of California San Francisco
Career Start Year 1985
Number of shared co-authors 14
Russ B Altman
Stanford University
Career Start Year 1982
Number of shared co-authors 22
Philip E Bourne
University of Virginia
Career Start Year 1980
Number of shared co-authors 8
Chris Sander
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 11
Shoba Ranganathan
Macquarie University
Career Start Year 1972
Number of shared co-authors 3
Andras Fiser
Albert Einstein College of Medicine
Career Start Year 1968
Number of shared co-authors 6

Collaborators

Michael J E Sternberg
Imperial College London
Co-authored papers 18
Iddo Friedberg
Iowa State University
Co-authored papers 5
John C Chambers
Lee Kong Chian School of Medicine, Nanyang Technological University
Co-authored papers 5
Joban Sehmi
Co-authored papers 5
Predrag Radivojac
Indiana University
Co-authored papers 5
Sean D Mooney
University of Washington
Co-authored papers 5
Paul Elliott
Co-authored papers 5
Jaspal S Kooner
London NorthWest Healthcare NHS Trust
Co-authored papers 5
James Scott
Co-authored papers 5
Weihua Zhang
Imperial College London
Co-authored papers 5
Magdalena Kotlicka-Antczak
Medical University of Lodz
Co-authored papers 4
Mark I McCarthy
Co-authored papers 4
Michal Linial
Institute of Life Sciences, The Hebrew University of Jerusalem
Co-authored papers 4
Prajwal Bhat
Royal Holloway University of London
Co-authored papers 3
Enrico Lavezzo
University of Padova
Co-authored papers 3
Paolo Fontana
San Pio Hospital
Co-authored papers 3
Gon??alo R Abecasis
Regeneron Pharmaceuticals Inc.
Co-authored papers 3
Fran Supek
Catalan Institution for Research and Advanced Studies (ICREA)
Co-authored papers 3
Haixuan Yang
University of Galway
Co-authored papers 3
Hai Fang
University of Bristol
Co-authored papers 3
Stefano Toppo
University of Padova
Co-authored papers 3
Patricia C Babbitt
University of California san francisco
Co-authored papers 3
Asa Ben-Hur
Colorado State University
Co-authored papers 3
Daisuke Kihara
Purdue University
Co-authored papers 3
David T Jones
University College London
Co-authored papers 3
Steven E Brenner
University of California berkeley
Co-authored papers 3
Rita Casadio
Department of Pharmacy and Biotechnology, University of Bologna
Co-authored papers 3
Burkhard Rost
Technical University of Munich (TUM)
Co-authored papers 3
Aimo Ruokonen
Co-authored papers 3
Domenico Cozzetto
Imperial College London
Co-authored papers 3
Release 1.2